Scitaris & Co KG

Executive Summary

Scitaris & Co KG is a Munich-based strategy consulting firm specializing in biopharma and biotech R&D. Founded in 2018, it provides science-driven guidance to pharmaceutical and biotechnology clients, focusing on preclinical development, clinical strategy, and portfolio optimization. The firm's PhD-trained team helps de-risk decisions and streamline development pathways, positioning it as a trusted partner for emerging and established life science companies. Despite a competitive landscape, Scitaris has carved a niche through deep technical expertise and a lean, partner-led model. Looking ahead, the company is poised to capitalize on the growing demand for specialized consulting as the biotech sector navigates complex regulatory and scientific challenges. Its private, pre-revenue status suggests early-stage growth with potential for expansion into new geographies or service lines.

Upcoming Catalysts (preview)

• Q4 2026Strategic partnership with a top-20 pharma company for long-term advisory40% success
• Q1 2027Launch of a digital platform for R&D portfolio analytics30% success
• Q3 2026Hiring of a senior partner with extensive regulatory expertise60% success